St. Louis Arch Angels
65
1M
56
3.42
3
0.14
4
- Stages of investment
- Areas of investment
Summary
In 2005 was created St. Louis Arch Angels, which is appeared as VC. The main office of represented VC is situated in the St Louis. The venture was found in North America in United States.
The overall number of key employees were 3.
Comparing to the other companies, this St. Louis Arch Angels performs on 26 percentage points less the average number of lead investments. The high activity for fund was in 2013. The usual things for fund are deals in the range of 1 - 5 millions dollars. The typical startup value when the investment from St. Louis Arch Angels is 1-5 millions dollars. The top amount of exits for fund were in 2017. The fund is constantly included in 2-6 deals per year.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the St. Louis Arch Angels, startups are often financed by Cultivation Capital, Capital Innovators, BioGenerator. The meaningful sponsors for the fund in investment in the same round are Billiken Angels Network, iSELECT FUND, The Yield Lab. In the next rounds fund is usually obtained by Missouri Technology Corporation, BioGenerator, Prolog Ventures.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Medical Device, Biotechnology. Among the various public portfolio startups of the fund, we may underline Appistry, ImmunoPhotonics, Euclises Pharmaceuticals
Investments analytics
Analytics
- Total investments
- 65
- Lead investments
- 3
- Exits
- 4
- Rounds per year
- 3.42
- Follow on index
- 0.14
- Investments by industry
- Biotechnology (30)
- Health Care (26)
- Medical Device (11)
- Pharmaceutical (10)
- Medical (10) Show 103 more
- Investments by region
-
- United States (63)
- Argentina (1)
- Peak activity year
- 2015
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 25M
- Group Appearance index
- 0.45
- Avg. company exit year
- 9
- Avg. multiplicator
- 2.98
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Elira | 01 Jan 2015 | Health Care, Medical Device, Medical | Seed | United States, St Louis, Missouri | |
| Viosera Therapeutics | 01 Dec 2018 | Wellness, Medical, Pharmaceutical, Therapeutics | Seed | United States, California, Sunnyvale |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.